Summary
We report a 3-year-old Italian patient with the hyperornithinaemia, hyperammonaemia, homocitrullinuria (HHH) syndrome who presented with neurological deterioration after an intercurrent infection. Hyperammonaemia, coagulopathy and moderate hypertransaminasaemia were detected on hospital admission. Severe hepatocellular necrosis with hypertransaminasaemia (aspartate aminotransferase 20 000 UI/L, alanine aminotransferase 18 400 UI/L) and coagulopathy (PT < 5%) rapidly developed within few days, prompting evaluation for liver transplantation. A protein-restricted diet and arginine supplementation were immediately started, with a rapid improvement of the patient’s neurological conditions and normalization of liver function tests and blood ammonia. The diagnosis of HHH syndrome was based on the presence of the typical metabolic abnormalities. Molecular analysis of the SLC25A15 gene showed that the patient was heterozygous for two novel mutations (G113C and M273K). The diagnosis of HHH syndrome should be considered in patients with fulminant hepatitis-like presentations. Early identification and treatment of these patients can be life-saving and can avoid liver transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adachi T, Tanimura A, Asahina M (1963) A colorimetric determination of orotic acid. J Vitaminol (Kyoto) 127: 217–226.
Camacho JA, Obie C, Biery B, et al (1999) Hyperornithinaemia, hyperammonaemia, homocitrullinuria syndromes caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nature Genetics 22: 151–158.
Clayton PT (2002) Inborn errors presenting with liver dysfunction. Semin Neonatol 7(1): 49–63.
Dionisi Vici C, Bachmann C, Gambarara M, Colombo JP, Sabetta G (1987) Hyperornithinaemia–hyperammonaemia–homocitrullinuria: low creatine excretion and effect of citrulline, arginine or ornithine supplement. Pediatr Res 22: 364–367.
Gjessing LR, Lunde HA, Undrum T, Broch H, Alme A, Lie SO (1986) A new patient with hyperornithinaemia, hyperammonaemia and homocitrullinuria treated early with low-protein diet. J Inherit Metab Dis 9: 186–192.
Haust MD, Gatfield PD, Gordon BA (1981) Ultrastructure of hepatic mitochondria in a child with hyperornithinaemia, hyperammonaemia and homocitrullinuria. Hum Pathol 12: 212–222.
Haust MD, Dewar RA, Gatfield DP, Gordon BA (1996) Hyper-ornithinaaemia–hyperammonaemia–homocitrullinuria (HHH)-syndrome. Ultrastructural changes of mitocondria in cultured dermal fibroblasts of three patients. Pathol Res Pract 192(3): 271–280.
Hommes FA, Ho CK, Roesel RA, Coryell ME, Gordon BA (1982) Decreased transport of ornithine across the inner mitochondrial membrane as a cause of hyperornithinaemia. J Inherit Metab Dis 5: 41–47.
Hoffmann GF (1996) Organic acid analysis. In: Blau N, Duran M, Blaskovics ME, eds. Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases. London: Chapman and Hall Medical, 31–49.
Korman SH, Kanazawa N, Abu-Libdeh B, Gutman A, Tsujino S (2004) Hyperornithinaemia, hyperammonaemia and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. J Neurol Sci 218: 53–58.
Salvi S, Santorelli MD, Bertini E, et al (2001) Clinical and molecular findings in hyperornithinaemia–hyperammonaemia–homocitrullinuria syndrome. Neurology 57: 911–914.
Shih VE, Efron ML, Moser HW (1969) Hyperornithinaemia, hyperammonaemia and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation. Am J Dis Child 117: 83–91.
Smith L, Lambert MA, Brochu P, Jasmin G, Qureshi IA, Seidman EG (1992) Hyperornithinaemia, hyperammonaemia, homocitrullinuria (HHH) syndrome: presentation as acute liver disease with coagulopathy. JPGN 15: 431–436.
Valle D, Simell O (2001) The hyperornithinaemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds; The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1857–1895.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Rodney Pollitt
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Fecarotta, S., Parenti, G., Vajro, P. et al. HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation. J Inherit Metab Dis 29, 186–189 (2006). https://doi.org/10.1007/s10545-006-0120-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0120-7